__NUXT_JSONP__("/drugs/Oblimersen_Sodium", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"190977-41-4",chebiId:"",chemicalFormula:"C172H204N62O91P17S17.17Na",definition:"The sodium salt of a phosphorothioate antisense oligonucleotide targeted to the initiation codon region of mRNA for the anti-apoptotic gene Bcl-2. Oblimersen inhibits Bcl-2 mRNA translation, which may result in decreased expression of the Bcl-2 protein and tumor cell apoptosis. This agent may enhance the efficacy of standard cytotoxic chemotherapy. The anti-apoptotic bcl-2 protein is an integral outer mitochondrial membrane protein (OMMP) that is overexpressed in some cancer cell types and is linked to tumor drug resistance.",fdaUniiCode:"SH55B0RQ9K",identifier:"C66722",preferredName:b,semanticType:"Pharmacologic Substance",subclassOf:["C1291"],synonyms:["Anticode G3139","Augmerosen","BCL-2 Antisense Oligodeoxynucleotide G3139","BCL-2 Antisense\u002FG3139","G3139","G3139 Antisense Oligonucleotide","G3139 BCL-2 Antisense Oligo","G3139 BCL-2 Antisense Oligodeoxynucleotide","G3139 BCL-2 Antisense Oligonucleotide","Genasense","OBLIMERSEN SODIUM",b,"augmerosen","bcl-2 antisense oligodeoxynucleotide G3139","oblimersen sodium"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FOblimersen_Sodium",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Oblimersen_Sodium","Oblimersen Sodium","2021-10-30T13:42:57.533Z")));